Kanishk Kharbanda Appointed As Director Of International Business
ncarol.com/10122157

MORRISVILLE, N.C. - ncarol.com -- BioMedomics, Inc. has announced that Mr. Kanishk Kharbanda has been appointed as Director of International Business with immediate effect. In his new role, Mr. Kharbanda will be responsible for the success of all outside-US operations which include sales, marketing, regulatory, logistics and manufacturing strategy. He will also be responsible for driving sales in Asia Pacific and EU regions.

With over 17 years' experience in international healthcare business, Kanishk has proven himself a visionary leader, strategic thinker, with a stellar reputation in the industry. Prior to joining BioMedomics Kanishk worked in business strategy consulting, market access, and public health program management in top companies and non-profit foundations. Kanishk earned his Master's in Business degree from the renowned Duke University's Fuqua School of Business and Bachelor's in Engineering degree from Manipal Institute of Technology.

More on ncarol.com

• Sara Abbas Receives "Eniochos" Charioteer Award at 2026 Who is Who International Awards
• Detained at 95: South Korea's Prosecution of a Religious Leader Draws International Alarm
• New from Regal House Publishing, The Withers, a desperate fight to defend loved ones
• CCHR: DOJ Takedown Exposes Over $220 Million Defrauded in Behavioral Mental Health Fraud Schemes
• Lady Liberty Is Coming Home: Historic WWII A-26 Invader Begins Her Final Journey to the Tulsa Air & Space Museum

"We are extremely fortunate and honored to have Kanishk as part of our Leadership Team", said Brad Heidinger, COO of BioMedomics. "Kanishk has been a great asset to our company in his previous role and I know he will continue to be impactful as our Director of International Business. He has an unquestionable skill set and is a real leader that brings both innovation and expertise.  He adds tremendous depth and value to our company."

"With our rich product pipeline and growing international customer base, we're at an inflection point as a company." said Kharbanda. "This brings ample challenges and opportunities - to grow and to streamline in lock step while delivering best-in-class customer experiences. A balancing act we're going to take head on."

For more information about BioMedomics, visit http://www.biomedomics.com